No description available.

Ruthenium-catalyzed cycloadditions of bicyclic alkenes with alkynyl phosphonates were investigated. In regard to the Ru-catalyzed [2+2] cycloadditions, the phosphonate moieties were found to be compatible, giving the corresponding cyclobutene cycloadducts in low to excellent yield (up to 96%). Alkynyl phosphonates showed lower reactivity than other heteroatom-substituted alkynes such as alkynyl halides, ynamides, alkynyl sulfides and alkynyl sulfones, and required a higher reaction temperature and much longer reaction time. To this end microwave heating was employed to expedite the reaction. While yields comparable to the conventionaly heated cycloadditions were not achieved, the reaction was much faster by microwave heating. In direct comparison over a 2 h period, yields were much greater in the microwave heated reactions. Computational studies determined that the electronic nature of the triple bond is sufficiently different in alkynyl phosphonates compared to other substituents. While investigating solvents of varying polarity in the microwave assisted [2+2] cycloaddition a new mode of reaction, previously unknown to this catalyst, was discovered. At elevated temperatures, in polar solvents, norbornadiene undergoes a Ru-catalyzed [2+2+2] homo Diels-Alder cycloaddition with alkynyl phophonates. This reaction was optimized to produce excellent yields with the model alkynyl phosphonate studied. Investigation of other alkynes revealed that the scope of this reaction may be limited to phosphonate substituted alkynes.

Recent work has shown that sulfones are unique synthetic tools capable of undergoing numerous transformations and reactions. The sulfone group is a strong electron withdrawing group and has the ability to stabilize an α-sulfonyl carbanion. As such, unsaturated sulfones can undergo a variety of reactions, i.e. conjugate additions, alkylation etc. Beside this, α sulfonyl carbanion can be generated with strong base and α sulfonyl carbanion can also be used in various reactions. This report is an investigation of a novel base induced cyclization of various alkynyl sulfones. The results revealed that the reaction does not significantly depend on the electronic effects of substituents in the aromatic ring. Additional versatility in this process was demonstrated with respect to a diverse array of functionality at various positions i.e. benzylic position, aromatic ring and terminal position of alkyne. These alkynyl sulfones, bearing a larger group at ortho position and any group at benzylic position underwent intramolecular cyclization when treated with base affording benzothiopyran S,S-dioxide. The results demonstrated that the cyclization efficiency was significantly influenced by the steric effects of substituents of aromatic ring at ortho positions and blocking the terminal position with phenyl since the cyclization reaction gave low or no yields with aromatic rings having a substituent at para, meta or to position than those having no substituent. It was also found that 2-thiophenylmethyl sulfones cyclize more efficiently than benzyl and furfuryl sulfones. The evidence from mechanistic studies points to a mechanism for the cyclization that involves disruption of aromaticity. To disrupt aromaticity, a deprotonation at benzylic position is a requirement for this cyclization reaction. Results suggest that the cyclization also requires an available hydrogen at the point where the potential ring would be fused. Several intermediates were also observed spectroscopically and identified by ReactIR®.

No description available.

Thesis advisor: X. Peter Zhang / Thesis advisor: James P. Morken / Chapter 1. Stereoselective Cyclopropanation of Alkenes with Alkynyl- and Vinyl-Substituted Diazo Compounds Alkynyl- and vinyl-substituted cyclopropanes are ubiquitous structural motifs in drug molecules and bioactive compounds. In addition, alkynyl- and vinyl-substituted cyclopropanes may serve as useful intermediates for stereoselective organic synthesis. Metal-catalyzed cyclopropanation of alkenes with alkynyl- and vinyl-substituted diazo compounds offers a potentially general approach for stereoselective construction of these valuable three-membered ring structures. This chapter summarizes the development of stereoselective olefin cyclopropanation with alkynyl- and vinyl-substituted diazo compounds. Chapter 2. Metalloradical Activation of In Situ-Generated α-Alkynyldiazomethanes for Asymmetric Radical Cyclopropanation of Alkenes We have developed a Co(II)-based metalloradical system that is highly effective for asymmetric radical cyclopropanation of alkenes with in situ-generated α-alkynyldiazomethanes. Through fine-tuning the cavity-like environments of D₂-symmetric chiral amidoporphyrins as the supporting ligand, the optimized Co(II)-based metalloradical system is broadly applicable to different alkynyldiazomethanes for asymmetric cyclopropanation of a broad range of alkenes, providing general access to valuable chiral alkynyl cyclopropanes in high yields with excellent diastereoselectivities and enantioselectivities. Chapter 3. Asymmetric Radical Process for Cyclopropanation of Alkenes with In Situ-Generated α-Vinyldiazomethanes We have demonstrated the feasibility of using vinyl aldehyde-derived sulfonylhydrazones as new metalloradicophiles for the generation of allylic radicals. Through fine-tuning the cavity-like environments of D₂-symmetric chiral amidoporphyrins as supporting ligands, the key α-Co(III)-allylic radical intermediates are exclusively engaged in the highly asymmetric cyclopropanation with wide-ranging alkenes in the optimized Co(II)-based metalloradical system, as shown broadly applicable to activate different α-vinyldiazomethanes. Chapter 4. Asymmetric Synthesis of Vinyl-Substituted Cyclopropanes by Radical C-H Alkylation from Alkynes and In Situ-Generated Alkyldiazomethanes via Co(II)-Based Metalloradical Catalysis We have successfully expanded the application of Co(II)-based MRC by applying in-situ generated alkyldiazomethanes as new radical precursors for stereoselective synthesis of vinyl-substituted cyclopropanes by radical cascade C-H alkylation of alkynes. Through fine-tuning of D₂-symmetric chiral amidoporphyrins as the supporting ligands, the Co(II)-catalyzed radical cascade process, which proceeds in a single operation under mild conditions, enables asymmetric construction of vinyl-substituted cyclopropanes in high yields with excellent diastereoselectivities and good enantioselectivities. / Thesis (PhD) — Boston College, 2022. / Submitted to: Boston College. Graduate School of Arts and Sciences. / Discipline: Chemistry.

Avec les réactions de macrocyclisation, il est possible d’ajouter de nouveaux groupements chimiques dans le macrocycle afin d’influencer ses propriétés biologiques. Les thioalcynes sont des groupements fonctionnels peu présents dans les macrocycles qui pourraient offrir de nouvelles possibilités de composés utilisables en chimie médicinale et qui ouvrent également la voie à plusieurs possibilités de diversification grâce à leur réactivité prévisible. Par conséquent, la mise au point d’une méthode de synthèse permettant formation de macrocycles peptidiques contenant des thioalcynes est intéressante. Ce mémoire présente ainsi le développement d’une stratégie de synthèse pour la formation de macrocycles tripeptidiques via la formation d’un connecteur thioalcyne par couplage croisé catalysé par un système [Cu(MeCN)4]PF6/dtbbpy/2,6-lutidine. Cette méthode a permis la synthèse de 4 macrocycles tripeptidiques possédant un thioalcyne avec des rendements compris entre 30% et 58%. Nous montrons aussi des possibilités de diversifications des macrocycles par l’utilisation du thioalcyne des macrocycles comme réactif. / Macrocyclization gives the opportunity to incorporate new functional groups in macrocycles to influence their biological properties. Rarely seen in macrocycles, alkynyl sulfides are functional groups that could be introduced into interesting compounds for applications in medicinal chemistry due to their ability to open new opportunities for diversification of the macrocyclic framework with its predictable reactivity. Consequently, the development of a synthetic strategy for the synthesis of macrocycles containing alkynyl sulfide in their structure is of interest. This thesis presents the development of a synthetic strategy for the formation of macrocyclic tripeptides using an alkynyl sulfide linker which is formed by cross coupling employing a [Cu(MeCN)4]PF6/dtbbpy/2,6-lutidine catalytic system. This method was used to generate 4 macrocyclic alkynyl sulfide tripeptides with yields ranging between 30% and 58%. This thesis also shows different possibilities for the diversification the macrocycle framework by using the alkynyl sulfide linker as a building block.

[Truncated abstract] This thesis describes various synthetic approaches toward the synthesis of highly conjugated complexes incorporating multiple transition metal centres. Particular attention is given to the synthesis of mononuclear complexes that allow for the facile assembly of discrete oligo- and poly-nuclear complexes in a controlled, stepwise fashion. Conjugated multi-metallic materials are of interest on account of their unique photophysical and electronic properties, with a particular emphasis on elucidating the nature of intramolecular communication between multiple metal centres. Chapter 1 provides a survey of these topics and current research efforts in the field. Chapter 2 describes the synthesis of Group-VIII allenylidene complexes incorporating a terminal bipyridyl moiety that provides a site for further coordination. The new compound 9-hydroxy-9-ethynyl-4,5-diazafluorene was synthesised, and reaction of this proligand with a coordinatively unsaturated metal fragment yields the allenylidene complexes [MCl(PnP)2=C=C=(4,5-diazafluoren-9-yl)]PF6 (M = Ru, PnP = dppm, dppe, dmpe; M = Os, PnP = dppm) and [CpRu(dppe)=C=C=(4,5-diazafluoren- 9-yl)]PF6. The dmpe-ligated complex is particularly susceptible to decomposition, though it was possible to obtain partial spectroscopic characterisation in addition to a single-crystal X-ray structural determination. The remaining allenylidene complexes are stable compounds readily characterised by standard spectroscopic and electrochemical means, with the bis(diphosphine) complexes characterised by single crystal X-ray structural determinations. ... Reactions of the proligand with [RuCl(PnP)2]+ (PnP = dppm, dppe) led to the isolation of a product spectroscopically consistent with the formation of the target cationic allenylidene complexes, though the complexes were not readily purified and the identity of the accompanying anion was not elucidated. The new compound 4-hydroxy-4- ethynyl-cyclopentadithiophene was also prepared, though the compound was found to be highly unstable and susceptible to rapid decomposition. The derived allenylidene complexes [RuCl(PnP)2=C=C=(4-cyclopentadithiophene)]PF6 (PnP = dppm, dppe) were isolated in a pure form and the complexes stable toward spontaneous decomposition. The thienyl-derived allenylidene complexes were characterised by spectroscopic and electrochemical techniques, with a single-crystal X-ray structural determination undertaken for [RuCl(dppm)2=C=C=(4-cyclopentaditiophene)]PF6. Electrochemical properties are significantly different between the complexes, and also show significant variation between electrodes and solvents. The terminal thienyl substituents are electroactive and show one or two oxidation processes consistent with oligomerisation of the thienyl moiety in dichloromethane solvent, and in acetonitrile solvent cyclic voltammograms are consistent with the deposition of an electroactive film on the electrode surface. The electro-polymerisation of the thienylallenylidene complexes offers a promising new route toward multi-metallic allenylidene complexes.

Conselho Nacional de Desenvolvimento Científico e Tecnológico / The liver presents extraordinary functional diversity, particularly in the control of energy production, immune defense and volemic reserve. The human being is exposed occupationally and in the environment to a variety of hepatotoxic compounds, such as the use of paints and their derivatives (2-nitropropane, 2-NP), chemical reagents (carbon tetrachloride, CCl4) and exposure to cigarette (2-NP). Therefore, it is interesting the study of therapies to prevent or even reverse the poisoning caused by these compounds. Considering that reactive oxygen species (ROS) have an important role in various diseases, especially in liver diseases, the use of antioxidant therapies should be considered. In this context, the heterocyclic compounds containing selenium in their structures have attracted the attention of researchers. Thus, this study investigated the antioxidant activity of 3-alkynyl selenophenes in models of oxidative damage in vitro and ex vivo in rats (Wistar, male, weighing 200-300g). A class of 3-alkynyl selenophene compounds with different substitutions was tested, with the objective to assess their antioxidant profile and their possible toxic effect in vitro. As a result, 3-alkynyl selenophenes had antioxidant activity, but this activity was dependent on the presence of terminal alkynes in the molecule or easy conversion to it. The possible toxic effect of 3-alkynyl selenophenes was evaluated through the activity of the enzyme δ-aminolevulinate dehydratase (δ-ALA-D) in vitro. The results showed that none of 3-alkynyl selenophenes inhibited the activity of this enzyme, suggesting that this class of compound did not present toxicity on this enzyme. From these results, selenophene h (compound that had the best antioxidant activity in vitro) was selected for the evaluation of its protective effect against oxidative damage induced by 2-NP and CCl4 (ex vivo). Selenophene h (25 mg/kg) protected against the increase of markers of liver damage (aspartate aminotransferase (AST) and alanine aminotransferase (ALT) activities) and oxidative stress induced by administration of 2-NP in rats. 2-NP induced microscopic changes, evaluated by histopathological inspections, that were protected by this compound. Selenophene h showed a protective effect against the increase of lipid peroxidation and inhibition of activity of δ-ALA-D in animals treated with 2-NP. Selenophene h protected against oxidative damage induced by CCl4 in rats. A single dose of CCl4 caused significant hepatotoxicity, evidenced by elevated plasma enzyme activity of AST and ALT, increased incidence of histopathological lesions, increased lipid peroxidation levels and the activity of Glutathione-S-transferase (GST), decreased levels of ascorbic acid and the activity of catalase and δ-ALA-D. In conclusion, 3-alkynyl selenophene protected from all these changes, confirming its hepatoprotective effect. Considering the results, we suggest that 3-alkynyl selenophene, an antioxidant, may be a useful therapy for the oxidative damage induced by 2-NP or CCl4 . / O fígado apresenta extraordinária pluralidade funcional, destacando-se no controle de produção de energia, defesa imunológica e reserva volêmica. No meio ambiente e ocupacionalmente, o ser humano está exposto a uma variedade de compostos hepatotóxicos, como por exemplo, no uso de tintas e seus derivados (2-nitropropano, 2- NP), reagentes químicos (tetracloreto de carbono, CCl4) e na exposição ao cigarro (2-NP). Portanto, é interessante o estudo de terapias que previnam ou até mesmo revertam a intoxicação causada por estes compostos. Considerando que as espécies reativas de oxigênio (EROs) apresentam importante papel sobre diversas patologias, em especial nas doenças hepáticas, o uso de terapias antioxidantes deve ser considerada. Neste contexto, destacam-se os compostos heterocíclicos contendo selênio em sua estrutura. Deste modo, neste estudo investigou-se a atividade antioxidante de 3-alquinil selenofenos em modelos de dano oxidativo in vitro e ex vivo em ratos (Wistar, machos, pesando entre 200 300 g). Para esse fim, testou-se uma classe de compostos 3-alquinil selenofeno, com diferentes substituições na estrutura química, com o objetivo de avaliar o perfil antioxidante e seu possível efeito tóxico in vitro em ratos. Como resultado, 3- alquinil selenofenos tiveram atividade antioxidante, porém esta atividade foi dependente da presença de um alquino terminal na molécula ou da fácil conversão da molécula a um alquino terminal. Além disso, o possível efeito tóxico dos 3-alquinil selenofenos foi avaliado através da atividade da enzima δ-aminolevulinato desidratase (δ-ALA-D) in vitro. Os resultados obtidos demonstraram que nenhum dos 3-alquinil selenofenos testados inibiu a atividade desta enzima, sugerindo que esta classe de compostos não apresentou toxicidade sobre a atividade da δ-ALA-D. A partir destes resultados, selecionou-se o selenofeno h (que obteve melhor atividade antioxidante in vitro) para a avaliação do seu efeito protetor contra o dano oxidativo induzido por 2-NP e CCl4 em ratos (ex vivo). O selenofeno h (25 mg/kg) protegeu contra o aumento dos marcadores de dano hepático (aspartato aminotranferase (AST) e alanina aminotransferase (ALT)) e de estresse oxidativo induzidos pela administração do 2-NP. O 2-NP induziu alterações microscópicas avaliadas por inspeções histopatológicas as quais foram protegidas pelo composto. O selenofeno h demonstrou efeito protetor contra o aumento da peroxidação lipídica e inibição da atividade da δ-ALA-D nos animais tratados com 2-NP. Além disso, o selenofeno h protegeu contra o dano oxidativo induzido pelo CCl4 em ratos. Uma única dose de CCl4 causou significante hepatotoxicidade, evidenciada por elevação da atividade plasmática das enzimas AST e ALT, aumento da incidência de lesões histopatológicas, aumento dos níveis de peroxidação lipídica e da atividade da enzima glutationa-S-transferase (GST), bem como diminuição dos níveis de ácido ascórbico e da atividade das enzimas catalase e δ-ALA-D. A partir dos resultados demonstrados, verificou-se que o selenofeno h protegeu contra todas estas alterações, confirmando o seu efeito hepatoprotetor. Considerando os resultados obtidos, pode-se sugerir que o selenofeno h, uma molécula com atividade antioxidante, pode ser uma útil terapia contra o dano oxidativo induzido pelos hepatotoxicantes: 2-NP e CCl4.

Conselho Nacional de Desenvolvimento Científico e Tecnológico / Seizures have important consequences in terms of mortality and quality of life of the affected population, being a risk factor for the development of cognitive and behavioral abnormalities. Considering the promising pharmacological properties of molecules containing selenium, in article 1, we evaluated the anticonvulsant action of 1-(2,5-diphenylselenophen-3-yl)-3-methylpent-1-yn-3-ol, generically called 3-alkynyl selenophene (3-ASP) against seizures induced by pilocarpine (PC), pentylenetetrazole (PTZ) and kainate (KA) in 21-days-old rats. Animals were pre-treated with 3-ASP (10, 25 or 50 mg/kg; per oral, p.o.) or vehicle, 30 minutes before of intraperitoneally administration of PC (400 mg/kg), PTZ (80 mg/kg) or KA (45 mg/kg). 3-ASP pre-treatment (50 mg/kg) abolished seizures and the death induced by PC administration. 3-ASP (50 mg/kg) increased the latency to the first convulsive episode, as well as decreased the mortality and incidence of seizures caused by PTZ and KA. In article 1, the antioxidant activity of 3-ASP (10, 25 or 50 mg/kg; p.o.) against the oxidative stress induced by PC (400 mg/kg, i.p.) in 21-days-old rats was evaluated. Our results demonstrated that 3-ASP pre-treatment was effective in protecting against the inhibition of cerebral activity of superoxide dismutase, decreased ascorbic acid levels, stimulation of catalase activity and increase of reactive species levels caused by PC. Additionally, 3-ASP protected against the inhibition of acetylcholinesterase and Na+, K+-ATPase activities resulting from convulsions induced by PC. The involvement of glutamatergic and GABAergic systems in the anticonvulsant action of 3-ASP was investigated (Articles 1 and 2). The combination of sub-effective doses of 3-ASP (10 mg/kg, p.o.) and diazepam (GABA agonist; 0,5 mg/kg, i.p.), 5S,10R-(+)-5-methyl-10,11-dihydro- 5H-dibenzo[a,d]cyclohepten-5,10-imine maleate (MK-801, a non-competitive N-methyl-D-aspartate (NMDA) receptor antagonist; 0.1mg/kg, i.p.) or 6,7-dinitroquinoxaline-2,3-dione (DNQX, a non-NMDA receptor antagonist; 5 mg/kg, i.p.) was effective in increasing the latency to the first convulsive episode, as well as, in decreasing the incidence of convulsions induced by PC. On the other hand, the combination of 3-ASP and 2-methyl-6-phenylethynyl pyridine hydrochloride (MPEP, an antagonist of metabotropic glutamate receptor mGluR5; 0,5 mg/kg, i.p.) did not protect against convulsions. The oral administration of 3-ASP (50 mg/kg) caused an inhibition of 64% and 58% of GABA uptake in the cortex and hippocampus, respectively. However, no change in glutamate uptake after 3-ASP administration (50 mg/kg) was found. Additionally, in article 2, we investigated the possible interaction between sub-effective doses of 3-ASP and GABA uptake or GABA transaminase (GABA-T) inhibitors against PC-induced seizures in 21-days-old rats. To this, sub-effective doses of 3-ASP (10 mg/kg; p.o.) and DL-2,4-diamino-n-butyric acid hydrochloride (DABA, an inhibitor of GABA uptake; 2 mg/kg; i.p.) or aminooxyacetic acid hemihydrochloride (AOAA; a GABA-T inhibitor; 10 mg/kg, i.p.) were co-administrated in 21-days-old rats before of PC administration (400 mg/kg). The treatment with 3-ASP and DABA abolished the PC-induced seizures. Similar results were found when sub-effective doses of 3-ASP and AOAA were administrated in 21-days-old rats. Finally, in the article 3 we investigated the effect of 3-ASP or diazepam against convulsions, the increased susceptibility to the development of seizures and long term memory impairment resulting from febrile seizures induced by hyperthermia. 21-Days-old rats were pre-treated with 3-ASP (25, 50 or 100 mg/kg; p.o), diazepam (1 or 5 mg/kg; i.p.) or vehicle. After the treatment, animals were exposed to a stream of heated air to approximately 41°C. Thirty days after the exposure to hyperthermia, the susceptibility to the development of seizures and long term memory impairment were evaluated. We verified that the pre-treatment with 3-ASP or diazepam did not protect against stereotyped behavior, facial automatisms and body flexion induced by hyperthermia. The protective effect of 3-ASP (100 mg/kg) against the increased susceptibility to the development of seizures and long term memory impairment resulting from febrile seizures induced by hyperthermia was demonstrated. Diazepam (1 or 5 mg/kg) did not protect against long term memory impairment caused by febrile seizures. In addition, diazepam (1 mg/kg) treatment caused a significant cognitive impairment in animals kept at room temperature. These results suggest that 3-ASP had anticonvulsant action in 21-days-old rats and that this action appears to be mediated by glutamatergic and GABAergic systems. In addition, the anticonvulsant action of 3-ASP seems to be associated with its antioxidant activity. Finally, 3-ASP can represent an important tool to protect against increased susceptibility to seizures and cognitive impairment resulting from febrile seizures. / As convulsões têm conseqüências importantes em termos de mortalidade e qualidade de vida da população afetada, sendo um fator de risco para o desenvolvimento de alterações cognitivas e anormalidades comportamentais. Tendo em vista as promissoras propriedades farmacológicas das moléculas contendo selênio, no artigo 1 avaliamos a ação anticonvulsivante do (1-(2,5-difenilselenofeno-3-il)-3-metilpent-1-in-3-ol, que foi genericamente denominado de 3-alquinil selenofeno (3-ASP) frente as convulsões induzidas por pilocarpina (PC), pentilenotetrazole (PTZ) e cainato (KA) em ratos de 21 dias de vida. Os animais foram pré-tratados com 3-ASP (10, 25 ou 50 mg/kg; per oral, p.o.) ou veículo, 30 minutos antes da administração intraperitoneal (i.p.) de PC (400 mg/kg), PTZ (80 mg/kg) ou KA (45 mg/kg). Verificamos que o pré-tratamento com 3-ASP (50 mg/kg) aboliu as convulsões e a morte induzidas pela administração de PC. O 3-ASP (50 mg/kg) aumentou a latência para o primeiro episódio convulsivo, bem como, diminuiu a mortalidade e a incidência das convulsões causadas por PTZ e KA. Ainda no artigo 1, consideramos importante o estudo da ação antioxidante do 3-ASP (10, 25 e 50 mg/kg; p.o.) frente ao estresse oxidativo induzido pela PC (400 mg/kg, i.p.) em ratos de 21 dias de vida. Os resultados demonstraram que o pré-tratamento com 3-ASP mostrou-se eficaz na proteção contra a inibição da atividade cerebral da superóxido dismutase, diminuição dos níveis de ácido ascórbico, estimulação da atividade da catalase e aumento dos níveis de espécies reativas causadas pela PC. Adicionalmente, o 3-ASP protegeu contra a inibição da atividade da acetilcolinesterase e da Na+,K+-ATPase resultantes das convulsões induzidas pela PC. Em um segundo momento, o envolvimento dos sistemas glutamatérgico e GABAérgico na ação anticonvulsivante do 3-ASP foi verificado (Artigos 1 e 2). A combinação de doses sub-efetivas de 3-ASP (10 mg/kg, p.o.) e diazepam (agonista GABAérgico; 0,5 mg/kg, i.p.), 5S,10R (+)-5-metil-10,11-dihidro-5H-dibenzo [a,d] ciclohepteno -5,10- imina maleato (MK-801; antagonista não-competitivo do receptor NMDA; 0.1mg/kg, i.p.) ou 6,7-dinitroquinoxalina-2,3-diona (DNQX; antagonista de receptores não-NMDA; 5 mg/kg, i.p.) aumentou a latência para o primeiro episódio convulsivo, bem como diminuiu a incidência de convulsões induzidas pela PC. Por outro lado, a combinação de 3-ASP e 2-metil-6-feniletinil piridina hidroclorada (MPEP; antagonista do receptor glutamatérgico metabotrópico do tipo 5; 0,5 mg/kg, i.p.) não apresentou efeito protetor contra os episódios convulsivos. A administração oral de 3-ASP (50 mg/kg) causou uma inibição de 64% e 58% da captação de GABA no córtex e no hipocampo, respectivamente. Entretanto, nenhuma alteração na captação de glutamato após a administração de 3-ASP (50 mg/kg) foi observada. Adicionalmente, no artigo 2 investigamos a possível interação entre doses sub-efetivas de 3-ASP e inibidores da captação de GABA ou da GABA transaminase (GABA-T) frente às convulsões induzidas por PC em ratos de 21 dias de vida. Para isto, doses sub-efetivas de 3-ASP (10 mg/kg; p.o.) e ácido DL-2,4-diamino-n-butírico hidroclorado (DABA - um inibidor da captação de GABA; 2 mg/kg; i.p.) ou ácido aminooxiacético hemihidroclorado (AOAA um inibidor da GABA-T; 10 mg/kg, i.p.) foram co-administrados em ratos de 21 dias de vida antes da administração de PC (400 mg/kg; i.p.). A presença de episódios convulsivos foi avaliada. Verificamos que o tratamento com o 3-ASP e DABA aboliu as convulsões induzidas por PC, corroborando com nossos resultados neuroquímicos. O mesmo foi observado quando foram administradas doses sub-efetivas de 3-ASP e AOAA. Por fim, no artigo 3 investigamos o efeito do 3-ASP ou diazepam frente as convulsões, aumento da susceptibilidade ao desenvolvimento de convulsões e prejuízo na memória a longo prazo resultantes da convulsão febril induzida pela hipertermia. Os ratos de 21 dias de vida foram pré-tratados com 3-ASP (25, 50 ou 100 mg/kg; p.o), diazepam (1 ou 5 mg/kg; i.p.) ou veículo. Após o pré-tratamento, os animais foram expostos a uma temperatura de 41°C. Trinta dias após a exposição à hipertermia, avaliamos o aumento da susceptibilidade ao desenvolvimento de convulsões e prejuízo na memória a longo prazo. Verificamos que o pré-tratamento com 3-ASP ou diazepam não foi capaz de proteger contra o comportamento estereotipado, automatismos faciais e flexão corporal induzidos pela hipertermia. O efeito protetor do 3-ASP (100 mg/kg) contra o aumento da susceptibilidade ao desenvolvimento de convulsões e prejuízo na memória a longo prazo resultantes da convulsão febril induzida pela hipertermia foi verificado. O diazepam (1 ou 5 mg/kg) não protegeu contra o prejuízo na memória a longo prazo causado pela convulsão febril. Além disso, o tratamento com diazepam (1 mg/kg) nos animais mantidos a temperatura ambiente causou um significativo prejuízo cognitivo. Estes resultados sugerem que o 3-ASP apresenta ação anticonvulsivante em ratos de 21 dias de vida e que essa ação parece ser mediada pelos sistemas glutamatérgico e GABAérgico. Além disso, a ação anticonvulsivante do 3-ASP parece estar associada à sua atividade antioxidante. Por fim, o 3-ASP pode representar uma importante ferramenta para a proteção contra o aumento à susceptibilidade às convulsões e o prejuízo cognitivo resultantes das convulsões febris.

Les réactions de macrocyclisation sont souvent difficiles à réaliser du point de vue expérimental, puisque la dilution élevée nécessaire requiert un montage encombrant et la purification du mélange est souvent complexe en raison d’une mauvaise sélectivité de cyclisation. Ces raisons peuvent compliquer la planification des voies de synthèse, ce qui dissuade souvent les chimistes d’utiliser les macrocycles pour différentes applications. Dans les dernières années, notre groupe de recherche a développé une méthode nommée stratégie de séparation de phase. Il s’agit d’un nouveau protocole permettant de faire des réactions de macrocyclisation de façon monotope et dans un milieu beaucoup plus concentré, tout en évitant les réactions parasites d’oligomérisation, facilitant ainsi la purification des macrocycles obtenus. Cette thèse décrit le développement et l’application de stratégies permettant de surmonter les défis liés aux réactions de macrocyclisation. Dans la première partie de la thèse, le protocole de la stratégie de séparation de phase a pu être utilisé pour la synthèse de squelettes macrocycliques complexes, comme celui du produit naturel ivorenolide A (Chapitre 4) et celui de l’anti-viral vaniprevir (Chapitre 6). Ce protocole a permis de réaliser l’étape de macrocyclisation dans un milieu réactionnel 120 fois plus concentré, tout en maintenant un niveau de sélectivité de macrocyclisation élevé. Dans la deuxième partie de la thèse, le développement d’une nouvelle synthèse d’acétylures de soufre catalysée par un complexe de cuivre a permis la synthèse d’une librairie de macrocycles peptidiques (Chapitre 8). L’incorporation du motif acétylure de soufre a aussi permis la diversification de ce dernier afin de greffer plusieurs étiquettes bioactives. Pour terminer, l’étendue de la réaction intermoléculaire de la nouvelle réaction de formation de thioalcynes a été explorée (Chapitre 9). Ceci a permis la synthèse d’alcynes disubstitués par des hétéroatomes ainsi que la fonctionnalisation de peptides contenant une cystéine non protégée. Des études mécanistiques expérimentales et computationnelles de la nouvelle méthode de synthèse de thioalcynes ont aussi été réalisées. / Macrocyclization reactions can be problematic due to poor selectivity of cyclization versus oligomerization. As such, difficult purification of complex mixtures and/or the use of complex and cumbersome experimental setups are often necessary. The drawbacks can complicate synthetic pathways and deter chemists from exploring the unique chemical space of macrocycles. Our group has developed a new macrocyclization strategy called phase separation strategy, a protocol enabling one-pot macrocyclization reactions at much higher concentration. In the present thesis, the challenges associated with macrocyclization reactions are tackled by the development and the application of new strategies. First, the phase separation strategy protocol was used to synthesize the backbone of complex macrocycles like the natural product ivorenolide A (Chapter 4) and the antiviral vaniprevir (Chapter 6). With the use of the phase separation strategy protocol, macrocyclization reactions were performed at concentrations 120 times higher than traditional protocols while maintaining a high level of macrocyclization selectivity. Second, the development of a new copper-catalyzed synthesis of alkynyl sulfides for the synthesis of a macrocyclic peptide library is described (Chapter 8). The macrocyclic peptides were also tagged with several biomarkers by diversification of the resulting alkynyl sulfide motif. Finally, the scope of the intermolecular copper-catalyzed reaction was explored (Chapter 9). Using the method, bis-heteroatom substituted alkynes were synthesized and modification of unprotected cysteine sidechains was possible. Furthermore, the mechanistic reaction pathway of the new alkynyl sulfide synthesis was studied experimentally and computationally.